A new study combines massively parallel assays, transcriptomics and biophysical modeling to provide a framework for analyzing the effects of compounds that modulate pre-mRNA splicing. The results lend important insights into the mechanisms of drug action and facilitate the design of splicing therapies.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Rogalska, M. E. et al. Nat. Rev. Genet. 24, 251–269 (2023).
Ishigami, Y. et al. Nat. Commun. 15, 1880 (2024).
Hoy, S. M. CNS Drugs 35, 1317–1328 (2021).
Naryshkin, N. A. et al. Science 345, 688–693 (2014).
Palacino, J. et al. Nat. Chem. Biol. 11, 511–517 (2015).
Paik, J. CNS Drugs 36, 401–410 (2022).
Campagne, S. et al. Nat. Chem. Biol. 15, 1191–1198 (2019).
Malard, F. et al. Nucleic Acids Res. 52, 4124–4136 (2024).
Sivaramakrishnan, M. et al. Nat. Commun. 8, 1476 (2017).
Wang, J. et al. Proc. Natl Acad. Sci. USA 115, E4604–E4612 (2018).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
J.V. is a member of the scientific advisory boards of Remix Therapeutics, Stoke Therapeutics and IntronX.
Rights and permissions
About this article
Cite this article
Herrero-Vicente, J., Black, D.L. & Valcárcel, J. Splice-modifying drug mechanisms. Nat Chem Biol 20, 1103–1105 (2024). https://doi.org/10.1038/s41589-024-01678-2
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41589-024-01678-2
